- Living Donor Liver Transplantation for Hepatocellular Carcinoma with Portal Vein Tumor Thrombus
-
YoungRok Choi, Kwang-Woong Lee, Hae Won Lee, Nam-Joon Yi, Kyung-Suk Suh
-
Journal of the Korean Liver Cancer Study Group. 2013;13(1):62-64. Published online February 28, 2013
-
DOI: https://doi.org/10.17998/jlc.13.1.62
-
-
Abstract
PDF
- Malignant portal vein thrombosis is a contraindication to liver transplantation for hepatocellular carcinoma because of the high
risk of its recurrence and the poor patient survival. With a newly developed immunosuppressant and a chemotherapeutic agent,
however, living donor liver transplantation can be considered for a patient of hepatocellular carcinoma, showing a slow growth
rate and good response for transarterial chemoembolization. We report a HBV related liver cirrhosis patient with HCC and portal
vein tumor thrombus who underwent living donor liver transplantation and survived without recurrence of hepatocellular
carcinoma for 18 months in our center.
|